Invention Grant
US09050324B2 Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
有权
用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮处理淀粉样变性的方法
- Patent Title: Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
- Patent Title (中): 用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮处理淀粉样变性的方法
-
Application No.: US14224974Application Date: 2014-03-25
-
Publication No.: US09050324B2Publication Date: 2015-06-09
- Inventor: Jerome B. Zeldis
- Applicant: Celgene Corporation
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: A61K31/4035
- IPC: A61K31/4035 ; A61K31/00 ; A61K31/198 ; A61K31/40 ; A61K31/425 ; A61K31/4439 ; A61K31/445 ; A61K31/454 ; A61K31/475 ; A61K31/515 ; A61K31/573 ; A61K31/675 ; A61K31/704 ; A61K31/7048 ; A61K35/12 ; A61K39/00 ; A61K39/395 ; A61K45/06

Abstract:
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Public/Granted literature
- US20140206723A1 METHODS FOR TREATING AMYLOIDOSIS WITH 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE Public/Granted day:2014-07-24
Information query
IPC分类: